Craig-Hallum analyst Alex Fuhrman maintained a Buy rating on LifeVantage (LFVN – Research Report) today. The company’s shares closed yesterday ...

Phase 3 of the Evolve Compensation Plan launches on March 1, 2025, furthering opportunities for successSALT LAKE CITY, March ...

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on LifeVantage (LFVN – Research Report) and ...

LifeVantage’s Q2 2025 results demonstrated strong growth driven by the launch of the MindBody GLP-1 System, leading to significant revenue gains and improved profitability metrics. The company ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and ...

The board of LifeVantage Corporation (NASDAQ:LFVN) has announced that it will pay a dividend on the 17th of March, with investors receiving $0.04 per share. Including this payment, the dividend ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are ...

LEHI, Utah (AP) — LEHI, Utah (AP) — Lifevantage Corp. (LFVN) on Wednesday reported profit of $2.6 million in its fiscal second quarter. On a per-share basis, the Lehi, Utah-based company said ...

SALT LAKE CITY, March 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at ...